VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESGO 2021 | PARP inhibitor rechallenging in ovarian cancer

Isabelle Ray-Coquard, MD, PhD, Léon Bérard Center, Lyon, France, talks on PARP inhibitor rechallenge which may demonstrate a benefit in patients with platinum-sensitive relapsed ovarian cancer. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter